Loss of cerebrovascular Shaker-type K+ channels: A shared vasodilator defect of genetic and renal hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Tobin, Ann A ^a   Joseph, Biny K ^d   Al Kindi, Hamood N ^b   Albarwani, Sulayma ^b   Madden, Jane A ^c   Nemetz, Leah T ^a   Rusch, Nancy J ^d   Rhee, Sung W ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cerebral arteries; Hypertension; Potassium channels; Vascular smooth muscle

Indexed keywords

CALCIUM; CORREOLIDE; MESSENGER RNA; POTASSIUM CHANNEL BLOCKING AGENT; PSORALEN DERIVATIVE; SHAKER POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL TONE; BRAIN ARTERY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; HEREDITARY HYPERTENSION; HYPERTENSION; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION; WESTERN BLOTTING; WISTAR KYOTO RAT;

ACETYLCHOLINE; ANIMALS; AORTA; BLOTTING, WESTERN; CEREBRAL ARTERIES; HYPERTENSION; HYPERTENSION, RENOVASCULAR; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 67650085055     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00991.2008     Document Type: Article

References (56)

1. + current in rabbit vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 271: H109-H119, 1996.
2. + channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol 551: 751-763, 2003.
3. Amberg GC, Santana LF. Downregulation of the BK channel beta1 subunit in genetic hypertension. Circ Res 93: 965-971, 2003.
4. v2 channels oppose myogenic constriction of rat cerebral arteries. Am J Physiol Cell Physiol 291: C348-C356, 2006.
5. + channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 95: 308-318, 2004.
6. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13: 968-972, 1989.
7. Beckh S, Pongs O. Members of the RCK potassium channel family are differentially expressed in the rat nervous system. EMBO J 9: 777-782, 1990.
8. Bohlen HG. Enhanced cerebral vascular regulation occurs by age 4 to 5 weeks in spontaneously hypertensive rats. Hypertension 9: 325-331, 1987.
9. v1 channels in vasoregulation. Circ Res 99: 53-60, 2006.
10. Vα1) subunits in terminal arterioles of rabbit. J Physiol 534: 691-700, 2001.
11. Vα1 channels in murine arterioles: differential cellular expression and regulation of diameter. Am J Physiol Heart Circ Physiol 281: H1057-H1065, 2001.
12. Chu S, Ferro TJ. Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation. Am J Physiol Lung Cell Mol Physiol 291: L983-L992, 2006.
13. + current in rabbit vascular myocytes. J Physiol 495: 689-700, 1996.
14. Cox RH. Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochem Biophys 42: 167-195, 2005.
15. + channels in small mesenteric artery myocytes from spontaneously hypertensive rats compared to Wistar-Kyoto rats. Am J Hypertens 16: 21-27, 2003.
16. + current components in mesenteric artery myocytes from WKY and SHR. Am J Hypertens 14: 897-907, 2001.
17. v1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflügers Arch 454: 451-459, 2007.
18. Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 265: H1847-H1855, 1993.
19. Faraci FM, Baumbach GL, Heistad DD. Myogenic mechanisms in the cerebral circulation. J Hypertens Suppl 7: S61-S65, 1989.
20. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53-97, 1998.
21. Felix JP, Bugianesi RM, Schmalhofer WA, Borris R, Goetz MA, Hensens OD, Bao JM, Kayser F, Parsons WH, Rupprecht K, Garcia ML, Kaczorowski GJ, Slaughter RS. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3. Biochemistry 38: 4922-4930, 1999.
22. v1.5 potassium channel gene regulation by Sp1 transcription factor and oxidative stress. Am J Physiol Heart Circ Physiol 293: H2719-H2725, 2007.
23. Frohlich ED. Is the spontaneously hypertensive rat a model for human hypertension? J Hypertens Suppl 4: S15-S19, 1986.
24. Gebremedhin D, Fenoy FJ, Harder DR, Roman RJ. Enhanced vascular tone in the renal vasculature of spontaneously hypertensive rats. Hypertension 16: 648-654, 1990.
25. Godfraind T, Kazda S, Wibo M. Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats. Circ Res 68: 674-682, 1991.
26. V1 family potassium channels. Mapping the domains of high affinity interaction. J Biol Chem 274: 25237-25244, 1999.
27. Harder DR, Brann L, Halpern W. Altered membrane electrical properties of smooth muscle cells from small cerebral arteries of hypertensive rats. Blood Vessels 20: 154-160, 1983.
28. Harder DR, Smeda J, Lombard J. Enhanced myogenic depolarization in hypertensive cerebral arterial muscle. Circ Res 57: 319-322, 1985.
29. + channels of rat arterial smooth muscle. Am J Physiol Heart Circ Physiol 281: H2480-H2489, 2001.
30. Heistad DD, Mayhan WG, Coyle P, Baumbach GL. Impaired dilatation of cerebral arterioles in chronic hypertension. Blood Vessels 27: 258 -262, 1990.
31. + channels expressed in the pulmonary vasculature. Circ Res 85: 489-497, 1999.
32. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation 12: 113-127, 2005.
33. Jackson WF, Huebner JM, Rusch NJ. Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles. Microcirculation 4: 35-50, 1997.
34. Johansson BB, Fredriksson K. Cerebral arteries in hypertension: structural and hemodynamic aspects. J Cardiovasc Pharmacol 7, Suppl 2: S90-S93, 1985.
35. Joseph BK, Rhee SW, Hirenallur DK, Rusch NJ. Potassium channels in vascular smooth muscle: structure, function and experimental intervention. In: New Frontiers in Smooth Muscle Biology and Physiology, edited by Savineau J-P. Trivandrum, Kerala, India: Transworld Research Network, 2007, p. 173-194.
36. Kaczorowski GJ, Garcia ML. Pharmacology of voltage-gated and calcium-activated potassium channels. Curr Opin Chem Biol 3: 448-458, 1999.
37. + channels in the regulation of basilar arterial tone in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 29: 575-581, 2002.
38. + channels in the cerebral microcirculation of genetically hypertensive rats: evidence for their protection against cerebral vasospasm. Circ Res 82: 729-737, 1998.
39. -ΔΔCT method. Methods 25: 402-408, 2001.
40. + channels in cerebral microvessels of hypertensive and normotensive rats. Anesth Analg 102: 571-576, 2006.
41. Osol G, Halpern W. Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol 249: H914-H921, 1985.
42. Pedrinelli R, Taddei S, Panarace G, Spessot M, Salvetti A. Calcium entry blockade and agonist-mediated vasoconstriction in hypertensive patients. J Cardiovasc Pharmacol 16, Suppl 2: S34-S39, 1990.
43. 2+ channels: is membrane depolarization the signal? Circ Res 94: e97-e104, 2004.
44. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39: 77-88, 1998.
45. Pollock DM. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 45: 477-480, 2005.
46. Smeda JS, Lombard JH, Madden JA, Harder DR. The effect of alkaline pH and transmural pressure on arterial constriction and membrane potential of hypertensive cerebral arteries. Pflügers Arch 408: 239-242, 1987.
47. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252, 2004.
48. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48: 309-319, 1981.
49. v1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol 65: 1364-1374, 2004.
50. v1.1 and 1.2 α subunits. Eur J Biochem 263: 222-229, 1999.
51. + channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest 100: 2347-2353, 1997.
52. 2+ entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol Heart Circ Physiol 281: H2559-H2567, 2001.
53. 2+ channels are comparable between simulated microgravity rat and SHR. Am J Physiol Heart Circ Physiol 289: H1265-H1276, 2005.
54. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98: 1400-1406, 1998.
55. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727, 1998.
56. v1.2 potassium channel S1-S2 linker: implications for linker secondary structure and the glycosylation effect on channel function. Biochem J 375: 769-775, 2003.